Opportunity for Patients with Grade 2 Glioma Brain Tumors with IDH1/IDH2 Mutations or Their Caregivers
REDMOND, WA, UNITED STATES, October 10, 2024 /EINPresswire.com/ -- The End Brain Cancer Initiative (EBCI) has partnered with Fulcrum Research Group to share an opportunity for those diagnosed with a Grade 2 Glioma brain tumor with IDH1/IDH2 mutations and …